FDA News & Notes - Week of October 24, 2011

SILVER SPRING, Md., Oct. 24, 2011 /PRNewswire-USNewswire/ -- Science, public health, and regulatory highlights from the U.S. Food and Drug Administration. Information in this document is designed for credentialed journalists. Release dates and times for items are current as of October 24, 2011.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

FDA News & Notes does not contain any regulatory or enforcement actions due to legal limitations.

Meetings, Workshops and Congressional Testimony:
Tuesday, 10/25 – Start of two-day Public Workshop – Magnetic Resonance Imaging Safety. The purpose of the workshop is to discuss factors affecting the safe use of magnetic resonance imaging and approaches to mitigate risks. Topics include general MRI safety, ferromagnetic detectors, scanning patients with medical implants, and the impact of innovation on MRI safety concerns. 8:30 a.m., both days, 10903 New Hampshire Ave., Building 31, Room 1503, Silver Spring, Md..

Press Office Contact: Erica Jefferson, 301-796-4988, [email protected]

Wednesday, 10/26 – The Circulatory System Devices Panel of the Medical Devices Advisory Committee begins a two-day meeting. On the first day, the committee makes recommendations and votes on the premarket approval application for the AtriCure Synergy Ablation System. During the second day, the committee considers and votes on the premarket approval application for the Medtronic Ablation Frontiers Cardiac Ablation System. 8 a.m., both days, Hilton Washington DC North/Gaithersburg, Salons A, B, C, and D, 620 Perry Pkwy., Gaithersburg, Md.  

Press Office Contact: Sandy Walsh, 301-796-4669, [email protected]

On the Web:
The Nunca Mas Novela Health Series, produced by the FDA's Office of Women's Health, uses soap operas to teach Hispanic women about safe medication use.

Press Office Contact: Patricia El-Hinnawy, 301-796-4763, [email protected]

Ready for Halloween? Check out the  Decorative Contact Lenses Web page for the risks associated with buying decorative contact lenses without a prescription.
Press Office Contact: Erica Jefferson, 301-796-4988, [email protected]

Baby Products with SIDS Prevention Claims
Press Office Contact: Erica Jefferson, 301-796-4674, [email protected]

Letter to Manufacturers Concerning SIDS Prevention Medical Claims for Baby Products
Press Office Contact: Erica Jefferson, 301-796-4674, [email protected]

Medical Device Pre-Market Programs: An Overview of FDA Actions
Press Office Contact: Karen Riley, 301-796-4674, [email protected]

Accomplishments: CDRH Plan of Action for 510(k) and Science
Press Office Contact: Karen Riley, 301-796-4674, [email protected]

FDA Communication on Use of Jet Injectors with Influenza Vaccines
Press Office Contact: Shelly Burgess, 301-796-4651, [email protected]

FDA Office of Public Affairs Contact Information:
Call or email FDA Office of Public Affairs, 301-796-4540, [email protected]
List of FDA press officers and beats

More Resources:
FDA News and Events

FDA Photos (Flickr)

Consumer Health Information

SOURCE U.S. Food and Drug Administration